← All trials
NCT06296082
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2024
- Primary completion
- Dec 30, 2025
- Completion date
- Dec 31, 2025
- First posted
- Mar 6, 2024
- Last posted
- Jun 24, 2024
- Enrollment
- 90
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of AntwerpLead sponsor
- McGill UniversityCollaborator
- European CommissionCollaborator
- University of ZaragozaOfficial
- Instituto de Investigación Sanitaria AragónCollaborator
- University of AntwerpSponsor investigator
- Government of BelgiumCollaborator
- Government of CanadaCollaborator
- Universidad Carlos III MadridCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.